# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
U.S. cannabis companies show resilience in Q2 2024, improving efficiency despite economic challenges. MSOs are focused on cutti...
Pennsylvania's recent budget approval excludes the legalization of recreational cannabis, marking a significant setback for...
Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state op...
In our January 2024 outlook, we asserted that cannabis equity analysts, having been burned by the need for continual downward r...
The conversation around cannabis legalization in Pennsylvania is pivoting towards a potential state-run model, akin to the exis...
Earnings for the 4th quarter of 2023 have largely been released, and the results were generally positive, with a few exceptions...
Connecticut's Record Sales In December Connecticut experienced a record-breaking December in 2023, with combined sales of ...
It wasn’t long ago when Ross Gerber, president and CEO of Gerber Kawasaki Wealth and Investment Management and an enthusiastic ...
Catholic nuns in Atlantic City, N.J.